- Home
- MXF vs ELDN Comparison
MXF vs ELDN Comparison
Compare MXF & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MXF
- ELDN
- Stock Information
- Founded
- MXF 1981
- ELDN 2004
- Country
- MXF Mexico
- ELDN United States
- Employees
- MXF N/A
- ELDN N/A
- Industry
- MXF Trusts Except Educational Religious and Charitable
- ELDN Biotechnology: Pharmaceutical Preparations
- Sector
- MXF Finance
- ELDN Health Care
- Exchange
- MXF Nasdaq
- ELDN Nasdaq
- Market Cap
- MXF 239.1M
- ELDN 202.4M
- IPO Year
- MXF N/A
- ELDN N/A
- Fundamental
- Price
- MXF $18.40
- ELDN $2.62
- Analyst Decision
- MXF
- ELDN Strong Buy
- Analyst Count
- MXF 0
- ELDN 2
- Target Price
- MXF N/A
- ELDN $12.50
- AVG Volume (30 Days)
- MXF 27.4K
- ELDN 662.1K
- Earning Date
- MXF 01-01-0001
- ELDN 08-14-2025
- Dividend Yield
- MXF 4.70%
- ELDN N/A
- EPS Growth
- MXF N/A
- ELDN N/A
- EPS
- MXF N/A
- ELDN 0.21
- Revenue
- MXF N/A
- ELDN N/A
- Revenue This Year
- MXF N/A
- ELDN N/A
- Revenue Next Year
- MXF N/A
- ELDN N/A
- P/E Ratio
- MXF N/A
- ELDN $12.17
- Revenue Growth
- MXF N/A
- ELDN N/A
- 52 Week Low
- MXF $14.77
- ELDN $2.38
- 52 Week High
- MXF $19.49
- ELDN $5.54
- Technical
- Relative Strength Index (RSI)
- MXF 59.85
- ELDN 43.04
- Support Level
- MXF $18.05
- ELDN $2.57
- Resistance Level
- MXF $18.50
- ELDN $2.84
- Average True Range (ATR)
- MXF 0.21
- ELDN 0.12
- MACD
- MXF -0.01
- ELDN 0.03
- Stochastic Oscillator
- MXF 85.52
- ELDN 31.82
About MXF Mexico Fund Inc. (The)
Mexico Fund Inc is a United States-based non-diversified, closed-end management investment company. Its investment objective is to seek long-term capital appreciation. The fund seeks to achieve its objective through investment in securities, primary in equity, listed on the Mexican Stock Exchange. The company's portfolio of investments consists of investments in different sectors such as auto parts, airports, building materials, chemical products, consumer products, energy, food, and other sectors. The fund provides a vehicle to investors who wish to invest in Mexican companies through a managed non-diversified portfolio as part of their overall investment program.
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.